ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för mosapride. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

19 träffar

Bibliografisk träff 2020-12-03

Oral mosapride can provide additional anti-emetic efficacy following total joint arthroplasty under general anesthesia: a randomized, double-blinded clinical trial.

Xie J, Cai Y, Ma J, Huang Q, Pei F, Pei F.

BMC Anesthesiol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1186/s12871-020-01214-4

Bibliografisk träff 2020-08-21

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis.

Nishizawa T, Mori K, Yoshida S, Ebinuma H, Toyoshima O, Suzuki H.

J Clin Med · research-article; journal article · DOI 10.3390/jcm9092705

Bibliografisk träff 2020-04-18

Pharmacokinetic analysis of mosapride following intravenous and oral administration in beagle dogs.

Kim MS, Baek IH.

J Vet Pharmacol Ther · randomized controlled trial, veterinary; journal article · DOI 10.1111/jvp.12867

Bibliografisk träff 2020-04-01

Mosapride Improves Lower Esophageal Sphincter and Esophageal Body Function in Patients With Minor Disorders of Esophageal Peristalsis.

Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kwon HJ, Kim GM, Joo HK.

J Neurogastroenterol Motil · research-article; journal article · DOI 10.5056/jnm19062

Bibliografisk träff 2020-01-01

Efficacy of mosapride citrate with a split dose of polyethylene glycol plus ascorbic acid for bowel preparation in elderly patients: A randomized controlled trial.

Lee J, Jeong SJ, Kim TH, Park YE, Choi JH, Heo NY, Park J, Park SH, Moon YS, Kim TO.

Medicine (Baltimore) · research-article; randomized controlled trial; journal article · DOI 10.1097/md.0000000000018702

Bibliografisk träff 2019-08-26

Gastroprokinetic agent, mosapride inhibits 5-HT<sub>3</sub> receptor currents in NCB-20 cells.

Park YS, Sung KW.

Korean J Physiol Pharmacol · research-article; journal article · DOI 10.4196/kjpp.2019.23.5.419

Bibliografisk träff 2019-07-26

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial.

Sirinawasatien A, Sirinawasatien A, Kantathavorn N.

Clin Exp Gastroenterol · research-article; journal article · DOI 10.2147/ceg.s214677

Bibliografisk träff 2019-07-18

Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats.

Krishna V, Bairy KL, Patil N, Sunny SV.

J Basic Clin Physiol Pharmacol · journal article · DOI 10.1515/jbcpp-2018-0089

Bibliografisk träff 2019-06-03

Effect of mosapride on ruminal motility in cattle.

Arai S, Haritani M, Sawada H, Kimura K.

J Vet Med Sci · research-article; journal article · DOI 10.1292/jvms.19-0196

Bibliografisk träff 2019-03-21

Effects of esophageal acid infusion vs mosapride on distension-induced secondary peristalsis in humans.

Lei WY, Hung JS, Yi CH, Liu TT, Wong MW, Chen CL.

Kaohsiung J Med Sci · research-article; journal article · DOI 10.1002/kjm2.12059

Bibliografisk träff 2019-03-20

The tissue distribution and excretion study of mosapride and its active des-p-fluorobenzyl and 4'-N-oxide metabolites in rats by ultra-high performance liquid chromatography-tandem mass spectrometry method.

Li K, Jiang X, Xiong Z, Qin F, Zhao L.

Xenobiotica · journal article · DOI 10.1080/00498254.2019.1588410

Bibliografisk träff 2018-12-11

The synthesis and biological evaluation of a new bioactive metabolite of mosapride as a potential gastroprokinetic agent.

Yao J, Li K, Song Y, He Z, Liu Z, Zhao L, Wang S.

Future Med Chem · journal article · DOI 10.4155/fmc-2018-0243

Bibliografisk träff 2018-06-01

Development and evaluation of orally disintegrating tablets containing the mosapride resin complex.

Wu T, Wang G, Shi C, Li J, Zhao N, Dong Z, Pan W, Zhang X.

Acta Pharm · journal article · DOI 10.2478/acph-2018-0017

Bibliografisk träff 2017-11-23

Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin-induced gastric injury.

Liu C, Duan Z, Guan Y, Wu H, Hu K, Gao X, Yuan F, Jiang Z, Fan Y, He B, Wang S, Zhang Z.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2017.5550

Bibliografisk träff 2017-08-16

Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl<sub>4</sub>-Induced Cirrhotic Rats.

Xu H, Xiong J, Xu J, Li S, Zhou Y, Chen D, Cai X, Ping J, Deng M, Chen J.

Dig Dis Sci · journal article · DOI 10.1007/s10620-017-4704-x

Bibliografisk träff 2017-04-13

Mosapride combined with probiotics on gastrointestinal function and growth in premature infants.

Zhang AM, Sun ZQ, Zhang LM.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2017.4340

Bibliografisk träff 2017-02-21

Electroacupuncture combined with mosapride alleviates symptoms in diabetic patients with gastroparesis.

Pan W, Wang Z, Tian F, Yan M, Lu Y.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2017.4139

Bibliografisk träff 2016-11-13

Mosapride for gastroesophageal reflux disease in neurologically impaired patients.

Komura M, Kanamori Y, Tanaka Y, Kodaka T, Sugiyama M, Terawaki K, Suzuki K, Iwanaka T.

Pediatr Int · clinical trial; journal article · DOI 10.1111/ped.13144

Bibliografisk träff 1989-07-01

AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.

Yoshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T.

Arch Int Pharmacodyn Ther · comparative study; journal article